Information and guidance from across SPS on pharmaceutical aspects of COVID-19 vaccines’ use

In temporary vaccination sites, good medicines governance will ensure safe and secure handling. Key issues are listed and implementation tools are provided.
Guidance on dosing for all available COVID-19 vaccines - reference to the vaccine specific pages provides supplementary information
Guidance on preparing and administering common to all available COVID-19 vaccines, and specific to individual vaccines
Prior allergy and religious or other dietary requirements could occasionally affect suitability for vaccination, and patients will often have questions.
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine Pfizer-BioNTech. Assumes the vaccine is received thawed.
Preparing vaccine using our SOPs, plus additional advice on diluent use, batch numbers, withdrawing additional doses and post-vaccination observation
The Pfizer-BioNTech COVID-19 vaccine must be defrosted before use. This page gives guidance on considerations whilst thawing the vaccine.
Information on intervals between dosing and completion of the vaccination schedule where an alternative brand of vaccine is given.
A summary of MHRA and JCVI guidance on use of AstraZeneca COVID-19 vaccine in age specific groups
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine AstraZeneca for a "drive-through" model.
Preparing vaccine using our SOPs, plus additional advice on batch numbers, withdrawing additional doses and post-vaccination observation
Information on intervals between dosing and completion of the vaccination schedule with an alternative brand of vaccine is given.